Cloned (Comment) | Organism |
---|---|
expression in S2 cells | Sus scrofa |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
50000 | - |
recombinant uPA, native PAGE | Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
piglets | - |
Purification (Comment) | Organism |
---|---|
recombinant uPA from S2 cells by immunoaffinity chromatography | Sus scrofa |
Source Tissue | Comment | Organism | Textmining |
---|
Subunits | Comment | Organism |
---|---|---|
monomer | 1 * 50000, recombinant uPA, SDS-PAGE | Sus scrofa |
Synonyms | Comment | Organism |
---|---|---|
uPA | - |
Sus scrofa |
Urokinase plasminogen activator | - |
Sus scrofa |
General Information | Comment | Organism |
---|---|---|
malfunction | urokinase plasminogen activator mediates impairment of hypercapnic and hypotensive cerebrovasodilation and pial artery dilation after cerebral hypoxia/ischemia, which is prevented by inhibition of integrin alphanubeta3, overview. Inhibition of uPA and integrin signaling may preserve cerebrohemodynamic control after hypoxia/ischemia | Sus scrofa |